Le médicament du mois, SEVIKAR/HCT° : association d'un antagoniste calcique (bésylate d'amlodipine), d'un inhibiteur des récepteurs de l'angiotensine II (olmésartan médoxomil) et d'un diurétique thiazide (hydrochlorothiazide)Krzesinski, Jean-Marie ![]() in Revue Médicale de Liège (2011), 66(12), 636-642 Hypertension is a common treatable risk factor for cardiovascular disease. Even when identified and treated, most patients with hypertension do not reach the blood pressure goal and they often need in ... [more ▼] Hypertension is a common treatable risk factor for cardiovascular disease. Even when identified and treated, most patients with hypertension do not reach the blood pressure goal and they often need in fact three antihypertensive agents to achieve blood pressure control. Although various combinations of two therapies are currently available for the treatment of hypertension, development of more powerful therapies with 3 molecules is necessary to control more hypertensive patients. Amlodipine/Olmesartan/hydrochlorothiazide (Sevikar/HCT°) is a new triple combination of antihypertensive agents that lower blood pressure via calcium channel blockade, angiotensin receptor blockade and diuretic action. Its potent triple mechanism of action is also likely to attenuate compound-specific adverse events, such as amlodipine-related peripheral oedema or sartan-induced hyperkalemia. Moreover, by reducing the number of pills to be taken every day, the compliance should be better. Currently available data show that such a combination is very powerful and well-tolerated allowing more patients with all grades of hypertension (especially those with the most severe forms) to reach the blood pressure target. The contraindications are those of each compound. [less ▲] Detailed reference viewed: 408 (4 ULg) Régulation du magnésiumKrzesinski, Jean-Marie ![]() Conference (2011, November 29) Detailed reference viewed: 12 (2 ULg) L'insuffisance rénale : fatalité liée à l'âge?Krzesinski, Jean-Marie ![]() Conference (2011, November 08) Detailed reference viewed: 8 (0 ULg) Régulation du potassiumKrzesinski, Jean-Marie ![]() Conference (2011, October 25) Detailed reference viewed: 7 (1 ULg) Physiopathologie du syndrome cardio-rénalKRZESINSKI, Jean-Marie ![]() Conference (2011, October 20) Detailed reference viewed: 17 (2 ULg) Reproducibility of blood pressure (BP) measurement techniques in late kidney transplantation (KT): the EPARA study; Saint-Remy, Annie ; WEEKERS, Laurent et alConference (2011, October 08) There has been a long debate about appropriate BP measurement techniques for evaluating the quality of BP control, especially in kidney transplantation (KT). Thus, one aim of the present study was to ... [more ▼] There has been a long debate about appropriate BP measurement techniques for evaluating the quality of BP control, especially in kidney transplantation (KT). Thus, one aim of the present study was to examine 3 methods of BP measurement and their reproducibility over a short period of 8 weeks. Conclusion: Home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM) should be applied more often also in KT, among others for reasons of better reproducibility over time than office blood pressure monitoring (OBPM). [less ▲] Detailed reference viewed: 13 (2 ULg) Which factors might explain the divergence between clinic and out-of-clinic blood pressure (BP) in kidney transplantation (KT): the EPARA study?; Saint-Remy, Annie ; BONVOISIN, Catherine et alConference (2011, October 08) Differences between clinic and out-of-clinic BP, defined as white coat effect (WCE), white coat hypertension (WCH) or masked hypertension (MH), can leat to misdiagnosis and -handling when decisions are ... [more ▼] Differences between clinic and out-of-clinic BP, defined as white coat effect (WCE), white coat hypertension (WCH) or masked hypertension (MH), can leat to misdiagnosis and -handling when decisions are solely based on clinic BP measurement. One aim of the study was to examine the risk factors of WCE and MH in late KT. Conclusion:Out-of-clinic BP monitoring should be encouraged to be applied more often in high risk-populations such as KT, especially when risk factors for WCE or MH are present. [less ▲] Detailed reference viewed: 13 (2 ULg) Tumor-induced osteomalacia: The tumor may stay hidden!; CAVALIER, Etienne ; KAUX, Jean-François et alin Clinical Biochemistry (2011), 44(14-15), 1264-6 We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth ... [more ▼] We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth factor 23 (FGF-23) was abnormally high and the diagnostic of tumor-induced osteomalacia was made. Despite multiple tests, the tumor was not localized. In this report, we discuss different possible investigations to localize the tumor. Lastly, we review the potential therapy available when tumor is not found and can thus not be excised. [less ▲] Detailed reference viewed: 43 (16 ULg) Etudes Bardoxolone, CCX et néphropathie diabétiqueKrzesinski, Jean-Marie ![]() Conference (2011, September 20) Detailed reference viewed: 8 (0 ULg) Détection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C?DELANAYE, Pierre ; CAVALIER, Etienne ; KRZESINSKI, Jean-Marie ![]() in Néphrologie & Thérapeutique (2011, September), 7(5), 298 Detailed reference viewed: 15 (3 ULg) Suivi à court et à long terme de la concentration de parathormone chez le patient hémodialysé: dosage de seconde et troisième générationDELANAYE, Pierre ; KRZESINSKI, Jean-Marie ; CAVALIER, Etienne ![]() in Néphrologie & Thérapeutique (2011, September), 7(5), 320 Detailed reference viewed: 14 (2 ULg) Suivi longitudinal des concentrations de PTH et de phosphatase alcaline osseuse chez le sujet hémodialysé: mesure-t-on la même chose?DELANAYE, Pierre ; KRZESINSKI, Jean-Marie ; CAVALIER, Etienne ![]() in Néphrologie & Thérapeutique (2011, September), 7(5), 324 Detailed reference viewed: 17 (2 ULg) Définition d'un débit de filtration "normal" fixe ou adapté à l'âge et au genre: impact sur l'épidémiologie de la maladie rénale chroniqueDELANAYE, Pierre ; CAVALIER, Etienne ; KRZESINSKI, Jean-Marie ![]() in Néphrologie & Thérapeutique (2011, September), 7(5), 404-405 Detailed reference viewed: 20 (3 ULg) Trimethoprim, creatinine and creatinine-based equationsDELANAYE, Pierre ; CAVALIER, Etienne ; et alin Kidney International (2011), 80(5), 439-40 Co-trimoxazole is a frequently prescribed antibiotic worldwide. It is composed of both trimethoprim and sulfamethoxazol (Sfx) and is used in the treatment and prophylaxis of urinary tract and Pneumocystis ... [more ▼] Co-trimoxazole is a frequently prescribed antibiotic worldwide. It is composed of both trimethoprim and sulfamethoxazol (Sfx) and is used in the treatment and prophylaxis of urinary tract and Pneumocystis jirovecii infections. The Sfx component appears to be nephrotoxic at high doses or doses inappropriately adjusted for glomerular filtration rate (GFR). The trimethoprim component, even at recommended doses, inhibits tubular creatinine secretion, leading to a rapid but ultimately reversible increase in serum creatinine independent of any changes in GFR. This translates into a falsely low estimated GFR when creatinine-based equations are used. This review focuses on evidence of the differential effects of trimethoprim and Sfx on serum creatinine concentrations and GFR and their relevance to clinical practice, with particular attention to kidney transplantation. [less ▲] Detailed reference viewed: 16 (5 ULg) Estimating glomerular filtration rate in Asian subjects: where do we stand?DELANAYE, Pierre ; CAVALIER, Etienne ; et alin Kidney International (2011), 80(5), 439-440 Detailed reference viewed: 12 (2 ULg) Hypophosphatémie et ostéomalacie oncogénique; CAVALIER, Etienne ; COLSON, Laurent et alin Revue Médicale Suisse (2011), 7 In this article, we will discuss about hypophosphatemia due to tumor-induced osteomalacia. This disease is characterized by severe muscular and articular tenderness inducing profound walking limitation ... [more ▼] In this article, we will discuss about hypophosphatemia due to tumor-induced osteomalacia. This disease is characterized by severe muscular and articular tenderness inducing profound walking limitation. Clinical chemistry results show severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth factor 23 (FGG-23) is abnormally high. Physiological role of FGF-23 is examined. We also consider the pathophysiology of tumor induced osteomalacia, the use of different investigations to localize the tumor and therapies available to treat this rare disease. [less ▲] Detailed reference viewed: 60 (5 ULg) Control of hypertension in renal transplantation : the EPARA study; SAINT-REMY, Annie ; WEEKERS, Laurent et alConference (2011, June 26) Blood pressure (BP) is a cardiovascular but also kidney disease risk factor, especially in high risk populations such as kidney transplantated one (KT). Therefore it must be accurately measured. The aim ... [more ▼] Blood pressure (BP) is a cardiovascular but also kidney disease risk factor, especially in high risk populations such as kidney transplantated one (KT). Therefore it must be accurately measured. The aim of the current study was to evaluate the quality of BP control in such a population followed at the CHU Liège. [less ▲] Detailed reference viewed: 27 (4 ULg) Native vitamin D in dialysis patients : safety and biological effectsWEEKERS, Laurent ; ; et alConference (2011, June 25) Native vitamine D (VTD) supplementation is recommended by the last KDIGO guidelines in CKD patients including dialysis patients. However, this recommendation is based on a low level of evidence. We ... [more ▼] Native vitamine D (VTD) supplementation is recommended by the last KDIGO guidelines in CKD patients including dialysis patients. However, this recommendation is based on a low level of evidence. We designed a randomized double-blind prospective study comparing the effects of VTD and placebo in dialysis patients on mortality, vascular calcifications and different paremeters: 25-OH vitamine D- 25(OH)D -, parathormone (PTH), calcium and phosphorus. [less ▲] Detailed reference viewed: 28 (0 ULg) Characteristics and evolution of hantavirus infection in Liège Area (Belgium)Krzesinski, Jean-Marie ; ; Poster (2011, June 24) Hantavirus is a zoonosis transmitted by rodents responsible in Europe for Hemorrhagic fever with acute renal syndrome (called nephropathia epidemica or NE). Hantavirus epidemics were increased in the ... [more ▼] Hantavirus is a zoonosis transmitted by rodents responsible in Europe for Hemorrhagic fever with acute renal syndrome (called nephropathia epidemica or NE). Hantavirus epidemics were increased in the recent years in the South part of Belgium. After acute illness, the question could be about its evolution. [less ▲] Detailed reference viewed: 6 (0 ULg) Practical issues in medication compliance in hypertensive patientsKrzesinski, Jean-Marie ; in Research Reports in Clinical Cardiology (2011), 2 Unsatisfactory compliance in the treatment of high blood presure is frequently due to sequential barriers, such as insufficient patient education about the illness and low motivation to receive any ... [more ▼] Unsatisfactory compliance in the treatment of high blood presure is frequently due to sequential barriers, such as insufficient patient education about the illness and low motivation to receive any treatment, existence of a large gap between physicians'perceptions of the problem and clinical reality, complexity of the treatment potentially generating adverse effects, and a health care environment with few public education compaigns and incentives for better coordinated supportive care. In order to improve drug compliance, establishment of personalized plans adapted to each patient is required. First, a good doctor-patient relationship is mandatory, with regular education of the patient about hypertension and its risks, discussion about adverse drug effects, and the complexity and cost of treatment. Second, to have any chance of success, the provider should offer convenient appointments and tailor the treatment regimen to the patient's lifestyle and needs, with written instructions. Third, there is a need to promote active patient collaboration with treatment. An innovative combination of home self-measurement of blood pressure, use of new technology options, eg, texting or telemedicine, and creation of a multi-disciplinary working team can offer new, effective opportunities. This approach could reduce cardiovascular complications by improving the control of high blood pressure, and thereby the overall costs of hypertension to the health care system. [less ▲] Detailed reference viewed: 29 (0 ULg) |
||